All In Biotech

Drug Trial Radar · NCT00665925

Efficacy and Safety Study of R935788 Tablets to Treat Rheumatoid Arthritis

A Phase II, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel Dose Study of Two Doses of R935788 in Rheumatoid Arthritis Patients Failing to Respond to Methotrexate

Last checked: Nov 20, 2026Latest source record: Sep 16, 2016 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registryPivotal-lookingRandomized with 457 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

457

Actual

Start

May 2008

Primary completion

Jun 2009

Study completion Jun 2009

Sponsor

Lead sponsor
Rigel PharmaceuticalsIndustry
Sponsor type
Industry
First posted
Apr 24, 2008

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Allocation
Randomized
Model
Parallel
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Treatment
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of this study is to determine whether the Spleen Tyrosine Kinase (Syk) inhibitor, R935788 (R788), at a dose of 100 mg, orally, twice-a-day, and/or a dose of of 150 mg, orally, once-a-day is effective in the treatment of Rheumatoid Arthrits in patients who have had an inadequate clinical response to methotrexate.

Conditions

  • Rheumatoid Arthritis

Interventions

  • Fostamatinib disodium (R935788)Drug

    100 mg tablet, orally, twice-a-day

  • Fostamatinib disodium (R935788)Drug

    150 mg tablet, orally, once a day

  • PlaceboDrug

    Placebo, orally, either once a day, or twice a day

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. American College of Rheumatology 20 (ACR20) Response at 6 MonthsTime frame: 6 months

Locations

65 sites in 6 countries. Site status is shown where the registry gives one.

  • Divison of Rheumatology Allergy and Immunology

    La Jolla, California

  • Desert Medical Advances

    Palm Desert, California

  • Arthritis & Osteoporosis Center, PC

    Hamden, Connecticut

  • Cynthia Morgan

    Washington D.C., District of Columbia

  • Florida Medical Research Institute

    Gainsville, Florida

  • Paddock Park Clinical Research

    Ocala, Florida

  • Jeffrey Poiley, MD

    Orlando, Florida

  • Lovelace Scientific Resources

    Sarasota, Florida

  • Rheumatology Associates, SC

    Chicago, Illinois

  • Memorial Medical Group Clinical Research Inst

    South Bend, Indiana

  • Center for Arthritis & Osteoporosis

    Elizabethtown, Kentucky

  • The Osteoporosis & Clinical Trials Center

    Hagerstown, Maryland

  • Fiechtner Research, Inc.

    Lansing, Michigan

  • Westroads Medical Group

    Omaha, Nebraska

  • North Carolina Arthritis & Allergy Care Center

    Raleigh, North Carolina

  • Wake Forest University

    Winston-Salem, North Carolina

  • Health Research of Oklahoma

    Oklahoma City, Oklahoma

  • Rheumatology Associates

    Erie, Pennsylvania

  • Clinical Research Center of Reading, LLP

    West Reading, Pennsylvania

  • Rheumatic Disease Associates

    Willow Grove, Pennsylvania

  • Rheumatology Associates

    Charleston, South Carolina

  • Austin Rheumatology & Research

    Austin, Texas

  • Arthritis Center of South Texas

    San Antonio, Texas

  • Arthritis Northwest, PLLC

    Spokane, Washington

  • MHAT Ruse

    Rousse, Bulgaria

  • DCC "Sv. Anna" Sofia

    Sofia, Bulgaria

  • MNTranspH "Tsar Boris Treti"

    Sofia, Gsof, Bulgaria

  • MHAT "Kaspela"

    Plovdiv, PLO, Bulgaria

  • Unidad Medica Torre Plaza

    Medellín, Antioquia, Colombia

  • Centro de Reumatologia y Ortopedia

    Barranquilla, Atlántico, Colombia

  • Reumatologos del Caribe

    Barranquilla, Atlántico, Colombia

  • CIREEM

    Bogota, Cundinamarca, Colombia

  • Fundación Instituto de Reumatología

    Bogota, Cundinamarca, Colombia

  • Riesgo de Fractura S.A

    Bogota, Cundinamarca, Colombia

  • Private Office

    Bogotá, Cundinamarca, Colombia

  • Centro Medico Carlos Ardila Lulle

    Bucaramanga, Santander Department, Colombia

  • SERVIMED

    Bucaramanga, Santander Department, Colombia

  • Christus Muguerza del Parque

    Chihuahua City, Chihuahua, Mexico

  • Arké Estudios Clínicos S.A de C.V

    México, D.f., Mexico

  • Clínica para el Diagnostico y Tratamiento de

    México, D.f., Mexico

Showing 40 of 65 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.